ZAI LAB(ZLAB)

Search documents
ZAI LAB(ZLAB) - 2023 Q2 - Earnings Call Transcript
2023-08-08 19:15
Zai Lab Limited. (NASDAQ:ZLAB) Q2 2023 Earnings Conference Call August 8, 2023 8:00 AM ET Company Participants Christine Chiou - Senior Vice President of Investor Relations Yajing Chen - Chief Financial Officer Samantha Du - Founder, Chairperson and Chief Executive Officer Josh Smiley - Chief Operating Officer Rafael Amado - President, Head of Global Oncology Research and Development Harald Reinhart - President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases Jonathan Wang - Chi ...
ZAI LAB(ZLAB) - 2023 Q2 - Quarterly Report
2023-08-06 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ____________________ Title of each class Trading Symbol(s) Name of each exchange on which registered American Depositary Shares, each representing 10 Ordinary Shares, par value $0.000006 per share ZLAB The Nasdaq Global Market Ordinary Shares, par value $0.000006 per share* 9688 The Stock Exchange of Hong Kong Limited FORM 10-Q ____________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHAN ACT ...
ZAI LAB(ZLAB) - 2023 Q1 - Earnings Call Transcript
2023-05-10 18:08
Zai Lab Limited. (NASDAQ:ZLAB) Q1 2023 Earnings Conference Call May 10, 2023 8:00 AM ET Company Participants Billy Cho - Chief Financial Officer Samantha Du - Founder, Chairperson and Chief Executive Officer Josh Smiley - Chief Operating Officer Rafael Amado - President, Head of Global Oncology Research and Development Harald Reinhart - President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases Jonathan Wang - Chief Business Development Conference Call Participants Michael Yee - ...
ZAI LAB(ZLAB) - 2023 Q1 - Quarterly Report
2023-05-08 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ____________________ FORM 10-Q ____________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHAN ACT OF 1934 For the quarterly period ended March 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHAN ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-38205 ____________________ ZAI LAB LIMITED (Exact Name of Registrant as Speci ...
ZAI LAB(ZLAB) - 2022 Q4 - Earnings Call Transcript
2023-03-02 18:50
Zai Lab Limited (NASDAQ:ZLAB) Q4 2022 Earnings Conference Call March 2, 2023 8:00 AM ET Company Participants Billy Cho - Chief Financial Officer Samantha Du - Founder, Chairperson and Chief Executive Officer Josh Smiley - Chief Operating Officer Rafael Amado - President, Head of Global Oncology Research and Development Harald Reinhart - President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases Jonathan Wang - Chief Business Development Conference Call Participants Michael Yee - ...
ZAI LAB(ZLAB) - 2022 Q4 - Annual Report
2023-02-28 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________ FORM 10-K __________________________ (Mark One) x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: December 31, 2022 Or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | --- | --- | |---------------------------------------------------------------------------------------------------|------------------------ ...
Zai Lab Limited (ZLAB) Presents at Citi Biotech C-Suite Fireside Chat Series Conference (Transcript)
2023-02-14 20:23
Zai Lab Limited (NASDAQ:ZLAB) Citi Biotech C-Suite Fireside Chat Series Conference Call February 14, 2023 11:00 AM ET Company Participants Josh Smiley - COO Conference Call Participants Yigal Nochomovitz - Citi Yigal Nochomovitz Okay, great. I’m Yigal Nochomovitz. I’m one of the biotech analysts here at Citi. This is a continuation of our newly introduced C-suite series where we feature management from some of our covered companies for a one-hour discussion about the pipeline and other topics. So, it’s my g ...
ZAI LAB(ZLAB) - 2022 Q3 - Earnings Call Transcript
2022-11-10 16:40
Zai Lab Limited (NASDAQ:ZLAB) Q3 2022 Results Conference Call November 10, 2022 8:00 AM ET Company Participants Billy Cho - Chief Financial Officer Samantha Du - Founder, Chairperson and Chief Executive Officer Josh Smiley - Chief Operating Officer Harald Reinhart - President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases Jonathan Wang - Chief Business Development Conference Call Participants Michael Yee - Jefferies Yigal Nochomovitz - Citi Anupam Rama - J.P. Morgan Ziyi Chen ...
ZAI LAB(ZLAB) - 2022 Q2 - Earnings Call Transcript
2022-08-10 18:16
Zai Lab Limited (NASDAQ:ZLAB) Q2 2022 Earnings Conference Call August 10, 2022 8:00 AM ET Company Participants Samantha Du - Founder, Chairperson and Chief Executive Officer Josh Smiley - Chief Operating Officer Billy Cho - Chief Financial Officer Alan Sandler - President, Head of Global Development, Oncology Harald Reinhart - President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases Jonathan Wang - Chief Business Development Conference Call Participants Michael Yee - Jefferies ...